Literature DB >> 486239

Neonatal effects of maternal clomipramine therapy.

A B Musa, C S Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 486239      PMCID： PMC1545555          DOI： 10.1136/adc.54.5.405-a

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  3 in total

1.  Possible teratogenicity of imipramine-chloropyramine.

Authors:  J Idänpään-Heikkilä; L Saxén
Journal:  Lancet       Date:  1973-08-11       Impact factor: 79.321

2.  Malformed infant.

Authors:  A J Barson
Journal:  Br Med J       Date:  1972-04-01

3.  Relationship between clinical features of tricyclic antidepressant poisoning and plasma concentrations in children.

Authors:  P Crome; R A Braithwaite
Journal:  Arch Dis Child       Date:  1978-11       Impact factor: 3.791
  3 in total
  5 in total

1.  Neonatal convulsions caused by withdrawal from maternal clomipramine.

Authors:  L Cowe; D J Lloyd; S Dawling
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-19

2.  Neonatal effects of maternal therapy with tricyclic antidepressant drugs.

Authors:  E Eggermont
Journal:  Arch Dis Child       Date:  1980-01       Impact factor: 3.791

3.  Clomipramine concentration and withdrawal symptoms in 10 neonates.

Authors:  Peter G J ter Horst; Susanne van der Linde; Jan Pieter Smit; Jan den Boon; Richard A van Lingen; Frank G A Jansman; Lolkje T W De Jong-van den Berg; Bob Wilffert
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

Review 4.  The Role of Metabolites of Antidepressants in the Treatment of Depression.

Authors:  M V Rudorfer; W Z Potter
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

Review 5.  Metabolism of tricyclic antidepressants.

Authors:  M V Rudorfer; W Z Potter
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.